transcatheter aortic valve replacement: a review article
Authors
abstract
transcatheter aortic valve replacement (tavr) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in high-risk patients for standard surgical procedures. since the initial partner trial results, use of tavr has been on the rise each year. new delivery methods and different valves have been developed and modified in order to promote the minimally invasive procedure and reduce common complications, such as stroke. this review article focuses on the current data on the indications, risks, benefits, and future directions of tavr. recently, tavr has been considered as a standard-of-care procedure. while this technique is used frequently in high-risk surgical candidates, studies have been focusing on the application of this method for younger patients with lower surgical risk. moreover, several studies have proposed promising results regarding the use of valve-in-valve technique or the procedure in which the valve is placed within a previously implemented bioprosthetic valve. however, ischemic strokes and paravalvular leak remain a matter of debate in these surgeries. new methods and devices have been developed to reduce the incidence of post-procedural stroke. while the third generation of tavr valves (i.e., edwards sapien 3 and medtronic evolut r) addresses the issue of paravalvular leak structurally, results on their efficacy in reducing the risk of paravalvular leak are yet to be obtained. furthermore, tavr enters the field of hybrid methods in the treatment of cardiac issues via both surgical and catheter-based approaches. finally, while tavr is primarily performed on cases with aortic stenosis, new valves and methods have been proposed regarding the application of this technique in aortic regurgitation, as well as other aortic pathologies. tavr is a suitable therapeutic approach for the treatment of aortic stenosis in high-risk patients. considering the promising results in the current patient population, recent studies have been conducted to evaluate the efficacy of this approach as a standard-of-care procedure.
similar resources
Transcatheter Aortic Valve Replacement: A Review Article
Transcatheter aortic valve replacement (TAVR) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in high-risk patients for standard surgical procedures. Since the initial PARTNER trial results, use of TAVR has been on the rise each year. New delivery methods and different valves have been developed and modified in order to promote the minimally invasive p...
full textTranscatheter Aortic Valve Replacement: A Review Article
Article type: Review article Transcatheter aortic valve replacement (TAVR) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in highrisk patients for standard surgical procedures. Since the initial PARTNER trial results, use of TAVR has been on the rise each year. New delivery methods and different valves have been developed and modified in order to prom...
full textTranscatheter Aortic Valve Replacement
With the worldwide number of TAVR procedures rapidly approaching 200,000, coupled with an amassed knowledge spanning over a decade, we are able to now reflect on the evolution of TAVR and how changes in technology, operator/institution experience, and patient selection have ultimately affected clinical outcomes. With this in mind, in this issue of JACC: Cardiovascular Interventions, Beohar et a...
full textTranscatheter Aortic-Valve Replacement.
Case History: A 77-year-old man presents with fatigue and shortness of breath with minimal exertion. He is brought into the examination room in a wheelchair due to shortness of breath with ambulation. He has a history of hypertension, diabetes mellitus, and coronary artery disease with prior stent to left anterior descending artery. Examination is notable for a harsh III/VI late-peaking systoli...
full textTranscatheter Aortic Valve Replacement 2016
Ma Transcatheter aortic valve replacement (TAVR) has become a safe and effective therapy for patients with severe aortic stenosis (AS). In recent trials, the hemodynamic performance and clinical outcomes of the latest generation of TAVR devices demonstrated at least parity with surgical outcomes in patients of similar risk. Many initial obstacles with TAVR have largely been overcome, including ...
full textAortic regurgitation after transcatheter aortic valve replacement.
Paravalvular aortic regurgitation (AR) negatively affects prognosis following transcatheter aortic valve replacement (TAVR). As transcatheter heart valves (THV) are anchored using a certain degree of oversizing at the level of the aortic annulus, incomplete stent frame expansion because of heavily annular calcifications, suboptimal placement of the prosthesis, and/or annulus-prosthesis size-mis...
full textMy Resources
Save resource for easier access later
Journal title:
journal of cardio-thoracic medicineجلد ۴، شماره ۲، صفحات ۴۲۳-۴۳۶
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023